Exagen Inc. Gains 30.39%

Exagen Inc. (XGN:NASDAQ) rocketted at $3.99, a gain of 30.4%. On Fri, Jan 17, 2025, XGN:NASDAQ hit a New 2-Week High of $3.99. The stock got featured on our News Catalysts scanner on Sun, Jan 12, 2025 at 01:58 PM in the 'BIOTECH' category. From Fri, Jan 03, 2025, the stock recorded 33.33% Up Days and 50.00% Green Days

About Exagen Inc. (XGN:NASDAQ)

Exagen Diagnostics Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.